MedTrace Logo

Aspire2B Personalization Pilot Study Program

NCT06191822 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000

Last updated 2024-01-05

No results posted yet for this study

Summary

This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.

Conditions

  • App Proficiency
  • Behavior
  • Lifestyle

Interventions

OTHER

Nutrition

Interact with mobile app and work toward personalized nutrition goals

OTHER

Fitness

Interact with mobile app and work toward personalized fitness goals

OTHER

Sleep

Interact with mobile app and work toward personalized sleep goals

Sponsors & Collaborators

  • PepsiCo Global R&D

    lead INDUSTRY

Principal Investigators

  • Tristin Brisbois, PhD, MBS · PepsiCo Global R&D

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06191822 on ClinicalTrials.gov